Trial intelligence / Profile preview

Pharmacodynamics of Meropenem in VAP

NCT02615041Phase 4Completed

Start
Jan 2004
Primary completion
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of meropenem in ventilator-associated pneumonia (VAP). Started Jan 2004; status: completed.

02

Drugs

meropenem
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on NCT02615041.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02615041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call